Cargando…

Anti-Inflammatory Drugs Reduce the Risk of Hepatocellular Carcinoma Development

Nowadays, patients with chronic hepatitis C in all countries are generally treated with interferon (IFN), and more than 50% of patients become HCV-RNA negative following PEG-IFN plus ribavirin therapy, but unfortunately, the IFN therapy is not effective in about 70% of patients with HCV-associated L...

Descripción completa

Detalles Bibliográficos
Autores principales: Rino, Yasushi, Tarao, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195877/
https://www.ncbi.nlm.nih.gov/pubmed/22084728
http://dx.doi.org/10.5402/2011/390676